With over 12,000 patents filed within MedTech in 2016, over 40% of these originated from Europe. Furthermore, of the over $1 billion invested every year in Swiss startups, $600 million of this is funneled towards healthcare. From these numbers, it is clear – MedTech is booming.
Unfortunately, due to the vast amount of money and companies entering the industry, it is a difficult process to filter which start-ups are truly promising, and which aren’t. This process requires vast amounts of experience in various fields ranging from Medical to Legal, financial and more.
Another hurdle that must be cleared is the fact that many investment funds are unable to take part in private equity.
With each of these hurdles in place, despite the amount of money flowing into the industry, many of the best opportunities remain either hard to spot, or simply out of reach.
lueOcean Ventures is an investment firm that possesses experts in the following fields. By having a diverse cast of experts, the firm has a history of selecting successful start-ups. Currently, this team is actively building their second fund. This is known as the BlueOcean Ventures II. This fund currently has holdings in 5 different companies within the MedTech industry. The firm is looking to both expand and increase their holdings in these companies.
To achieve their goal of expansion and increased exposure, BlueOcean is hosting an STO. This STO will allow accredited investors the ability to invest in pre-vetted start-ups. This means that they can take advantage of the wide array of skills the BlueOcean team brings to the table.
By utilizing blockchain technology, the investors in the fund will benefit from not only increased transparency (where are the funds being spent), but also from increased levels of liquidity. As there is no lock-up period on the BlueOcean tokens (BOV), investors will be able to trade their tokens on secondary markets in a short amount of time. Tokens are expected to be listed on cryptocurrency exchanges by Q1 of 2019.
With their STO currently active, BlueOcean will be preparing for token distribution. Once complete, the funds garnered throughout the STO will be able to be put to use, and begin working for the investors that participated. BlueOcean indicates that 100% of these funds will be invested in BlueOcean Ventures II.
For those looking to invest in MedTech start-ups via a curated fund, check out the BlueOcean STO; The easiest way to gain indirect equity in these promising start-ups.
The fund is scheduled to close in 2025. Upon closure, all assets will be proportionately divvied up among remaining investors.
BEGINNING OF 2019
Attention. There is a risk that unverified members are not actually members of the team
This offer is based on information provided solely by the offeror and other publicly available information. The token sale or exchange event is entirely unrelated to ICOholder and ICOholder has no involvement in it (including any technical support or promotion). Token sales listed from persons that ICOholder has no relationship with are shown only to help customers keep track of the activity taking place within the overall token sector. This information is not intended to amount to advice on which you should rely. You must obtain professional or specialist advice or carry out your own due diligence before taking, or refraining from, any action on the basis of the content on our site. Any terms and conditions entered into by contributors in respect of the acquisition of Tokens are between them and the issuer of the Token and ICOholder is not the seller of such Tokens. ICOholder has no legal responsibility for any representations made by third parties in respect of any Token sale and any claim for breach of contract must also be made directly against the Token issuing entity listed herein.
If you have any concerns about the nature, propriety or legality of this token sale or the persons involved in it please contact [email protected] with detailed information about your concerns.